Martha Churchill Bohn, PhD is a Professor in the Department of Pediatrics and the Department of Molecular Pharmacology and Biological Chemistry at the Feinberg School of Medicine, Northwestern University. She is Director of the Neurobiology Program at Children's Memorial Research Center (CMRC). Dr. Bohn served as Interim Director of the CMRC from 2001 to 2003. Dr. Bohn received her AB degree in Chemistry from Cornell University and her PhD degree in Neuroscience from the University of Connecticut in 1979. She has held faculty positions at Cornell Medical College, the State University of New York at Stony Brook, and the University of Rochester Medical Center. Dr. Bohn serves on the editorial boards for Experimental Neurology, and Gene Therapy and Molecular Biology. She has served as President for the American Society for Neural Transplantation and Repair and President for the Chicago Chapter of the Society for Neuroscience. She has also served on many advisory boards for scientific societies, the National Science Foundation and the National Institutes of Health. She served from 2001 to 2005 as a member of the NIH Recombinant DNA Advisory Committee that reviews all gene therapy clinical protocols and advises on policy related to the gene therapy field. Dr. Bohn also received an outstanding performance award from the National Science Foundation where she was Program Director for Developmental Neuroscience for two years. Dr. Bohn's research is focused on understanding development of the brain and generating novel therapies for neurodegenerative diseases, such as Parkinson's and Lou Gehrig's diseases. Her research program is supported by grants from the National Institutes of Health. Dr. Bohn has lectured extensively and has published over 100 articles in scientific journals and books. While Interim Director of CMRC, Dr. Bohn founded a novel program called CRIB (Children's Research on Injury to the Brain) to promote the translation and application of neuroscience research to diseases and injuries of children. She is also involved in several translational research projects aimed at getting novel gene therapies to the clinic for Parkinson's disease. Dr. Bohn recently established a viral vector translational resource center to facilitate the translation of basic science to the clinic in the field of gene therapies for neurodegenerative diseases and injuries to the nervous system.